Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure.
Red blood cell exchange is an accepted superior therapy to simple chronic transfusion, due to minimal risk of iron overload, for secondary prevention of cerebrovascular accidents in selected patients with sickle cell anemia. Recently, we described our experience of Isovolemic Hemodilution-Red Blood Cell Exchange (IHD-RBCx), a two-step modification of the conventional RBCx with several advantages, including cost reduction. We are describing our standard operating procedure for IHD-RBCx with COBE Spectra apheresis system to make it widely available to the apheresis centers interested in implementing this procedure.
Karén
K
Matevosyan
Christina
C
Anderson
Ravi
R
Sarode
D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood*; D001781:Blood Component Removal / Q000379:methods; D001803:Blood Transfusion / Q000379:methods*; D002648:Child; D003201:Computers; D017707:Erythrocyte Transfusion / Q000379:methods* / Q000592:standards*; D004912:Erythrocytes / Q000166:cytology*; D006400:Hematocrit / Q000379:methods; D006438:Hemodilution / Q000379:methods* / Q000592:standards*; D006801:Humans; D008875:Middle Aged; D012984:Software; D020521:Stroke / Q000097:blood*; D013997:Time Factors